文献速递脑血管病

症状性非狭窄颈动脉:专题综述

Symptomatic Nonstenotic Carotids: A Topical Review.
PubMed 文献 · Stroke · 2024-10-11

本综述回顾颈动脉疾病管理历史,提出症状性非狭窄颈动脉(狭窄<50%但同侧斑块具高风险特征)概念,汇总斑块易损性生物标志物、影像工具及近期临床研究,并呼吁生成高级别证据以更新临床管理。

要点

  • 当前指南以≥50%狭窄作为颈动脉病因判定阈值,狭窄<50%的斑块常被忽略。
  • 症状性非狭窄颈动脉指同侧斑块具斑块内出血、脂质坏死核心、纤维帽变薄/破裂或溃疡等高危特征。
  • 部分隐源性栓塞性卒中(占缺血性脑血管事件高达25%)可能源于未诊断的非狭窄动脉斑块破裂。

核心结论

  • 作者认为,将同侧颈动脉斑块具高风险特征且狭窄<50%的缺血性脑血管事件患者重新分类为症状性非狭窄颈动脉,有助于针对性治疗,并呼吁生成亟需的高级别证据以更新临床管理。

研究设计与样本

  • 专题综述,检索范围未在摘要中报告。

主要发现

  • 当前指南下,除非动脉粥样斑块导致≥50%狭窄,否则不认为是脑血管事件的原因。
  • 隐源性栓塞性卒中占所有缺血性脑血管事件高达25%,部分被认为源于未诊断的非狭窄动脉(狭窄<50%)斑块破裂的血栓栓塞现象。
  • 症状性非狭窄颈动脉的斑块高风险特征包括斑块内出血、脂质坏死核心、纤维帽变薄/破裂和溃疡。

关键数值与推荐

  • 当前指南以≥50%狭窄作为动脉粥样斑块导致脑血管事件的判定阈值。
  • 症状性非狭窄颈动脉定义为同侧颈动脉斑块具高风险特征且狭窄<50%。

临床怎么用

  • 作者提出应生成亟需的高级别证据,使症状性非狭窄颈动脉患者的临床管理与当代斑块破裂和血栓栓塞理解相一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Historically, the management of carotid artery disease has primarily focused on the degree of stenosis as the main indicator for assessing stroke etiology, risk, and need for intervention. However, accumulating evidence suggests that structural and biological features within the arterial wall, such as intraplaque hemorrhage, may have superior diagnostic, prognostic, and therapeutic values. Under current guidelines, unless an atheroma results in ≥50% stenosis, it is not considered the cause of a cerebrovascular event. This results in extensive and often unproductive diagnostic workup, prescription of ineffective medical therapy, and preclusion of patients from receiving revascularization procedures that have been shown to prevent recurrent cerebrovascular events in cases of ≥50% stenosis. A subset of embolic strokes of undetermined source, which account for up to 25% of all ischemic cerebrovascular events, are thought to be due to thromboembolic phenomena from undiagnosed plaque disruptions in nonstenotic arteries (<50% stenosis). Recently, it has been proposed to reclassify this subgroup of patients as symptomatic nonstenotic carotid if the carotid plaque ipsilateral to the cerebrovascular event presents with high-risk features including intraplaque hemorrhage, lipid-rich necrotic core, thinning/rupture of the fibrous cap, and ulceration. In this review, we first provide a historical overview of the chain of events and circumstances that resulted in the present management of carotid artery disease. Second, we embed the contemporary biomarkers of plaque vulnerability in a modern mechanistic paradigm of carotid plaque disruption and thromboembolization. Third, we review the clinically available imaging tools to detect these biomarkers, and how their use has started to shed light on the prevalence and natural history of this underdiagnosed condition. Fourth, we review recent clinical studies employing a contemporary definition of symptomatic nonstenotic carotid and discuss targeted treatments for this condition. Finally, we make a case to generate the much-needed high-level evidence to align the clinical management of patients with symptomatic nonstenotic carotid with a contemporary understanding of plaque disruption and thromboembolization.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Savastano L, Brinjikji W, Lutsep H, et al. Symptomatic Nonstenotic Carotids: A Topical Review. Stroke. 2024. PMID: 39391978. doi:10.1161/STROKEAHA.123.035675

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。